Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
10.51
+0.10 (0.96%)
At close: Mar 11, 2025, 4:00 PM
10.67
+0.16 (1.52%)
After-hours: Mar 11, 2025, 5:22 PM EST
Aligos Therapeutics Employees
Aligos Therapeutics had 66 employees as of December 31, 2023. The number of employees decreased by 17 or -20.48% compared to the previous year.
Employees
66
Change (1Y)
-17
Growth (1Y)
-20.48%
Revenue / Employee
$59,773
Profits / Employee
-$1,988,045
Market Cap
39.01M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 66 | -17 | -20.48% |
Dec 31, 2022 | 83 | -10 | -10.75% |
Dec 31, 2021 | 93 | 19 | 25.68% |
Dec 31, 2020 | 74 | 13 | 21.31% |
Dec 31, 2019 | 61 | - | - |
ALGS News
- 1 day ago - Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 8 days ago - Aligos Therapeutics to Announce 4th Quarter 2024 Financial Results on March 10, 2025 - GlobeNewsWire
- 27 days ago - Aligos Therapeutics Announces $105 Million Private Placement Financing - GlobeNewsWire
- 3 months ago - Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 months ago - Aligos Therapeutics Presents Positive Data at The Liver Meeting (TLM) 2024 - GlobeNewsWire
- 4 months ago - Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results - GlobeNewsWire
- 5 months ago - Aligos Therapeutics Appoints David Perry as Vice President of Business Development - GlobeNewsWire
- 5 months ago - Aligos Therapeutics to Present at Investor Conferences in October - GlobeNewsWire